Catalyst Wire Dossier Catalyst Wire Dossier

Ventavis (iloprost)

iloprost · Bayer
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Ventavis (iloprost), covering 2014-12-29 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Patient-Reported Outcomes and Adherence After Transition From Inhaled Iloprost to Oral Selexipag in Pulmonary Arterial Hypertension

See pricing